Lindsay Israel

Dr. Lindsay Israel is an interventional psychiatrist and is one of the founders of Success TMS, where she served as the Chief Medical Officer from 2018-2022 until the acquisition by Greenbrook TMS in August 2022.

She now holds the role of Chief Medical Development Officer for Greenbrook TMS, and is closely involved with the recruiting, training and ongoing education of TMS and Nasal Esketamine Spray providers with a goal of maintaining consistent quality patient care based on industry standards. She is the clinical support for all levels of clinical staff and takes part in developing new and innovative clinic programs that improve patient treatment outcomes. Dr. Israel has also served as a panel expert in the field of TMS. In addition, Dr. Israel provides in-services pertaining to TMS and Nasal Esketamine Spray therapy to therapists, primary care providers, and other subspecialty providers all over the country in order to help inform all communities about TMS and Nasal Esketamine Spray and how it can help their patients.